受容体チロシンプロテインキナーゼ標的薬の世界市場（～2026年）

• 英文タイトル：Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY08958 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は受容体チロシンプロテインキナーゼ標的薬のグローバル市場について調査・分析したレポートです。種類別（ジマレイン酸アファチニブ、ダコミチニブ、ネラチニブ、ニューカルディン、その他）市場規模、用途別（腫瘍、心臓血管、中枢神経系、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別受容体チロシンプロテインキナーゼ標的薬の競争状況、市場シェア ・世界の受容体チロシンプロテインキナーゼ標的薬市場：種類別市場規模 2015年-2020年（ジマレイン酸アファチニブ、ダコミチニブ、ネラチニブ、ニューカルディン、その他） ・世界の受容体チロシンプロテインキナーゼ標的薬市場：種類別市場規模予測 2021年-2026年（ジマレイン酸アファチニブ、ダコミチニブ、ネラチニブ、ニューカルディン、その他） ・世界の受容体チロシンプロテインキナーゼ標的薬市場：用途別市場規模 2015年-2020年（腫瘍、心臓血管、中枢神経系、その他） ・世界の受容体チロシンプロテインキナーゼ標的薬市場：用途別市場規模予測 2021年-2026年（腫瘍、心臓血管、中枢神経系、その他） ・北米の受容体チロシンプロテインキナーゼ標的薬市場分析：米国、カナダ ・ヨーロッパの受容体チロシンプロテインキナーゼ標的薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの受容体チロシンプロテインキナーゼ標的薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の受容体チロシンプロテインキナーゼ標的薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの受容体チロシンプロテインキナーゼ標的薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Aslan Pharmaceuticals Pte Ltd、Boehringer Ingelheim GmbH、GamaMabs Pharma SA、Hanmi Pharmaceuticals Co Ltd、Jiangsu Kanion Pharmaceutical Co Ltd、Minerva Neurosciences Inc、Pfizer Inc、Puma Biotechnology Inc、Shanghai Fosun Pharmaceutical (Group) Co Ltd、XuanZhu Pharma Co Ltd、Zensun (Shanghai) Sci & Tech Co Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Receptor Tyrosine Protein Kinase Targeted Drugs Market
The global Receptor Tyrosine Protein Kinase Targeted Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Receptor Tyrosine Protein Kinase Targeted Drugs Scope and Market Size
Receptor Tyrosine Protein Kinase Targeted Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Receptor Tyrosine Protein Kinase Targeted Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Receptor Tyrosine Protein Kinase Targeted Drugs market is segmented into
Afatinib Dimaleate
Dacomitinib
Neratinib
Neucardin
Others

Segment by Application, the Receptor Tyrosine Protein Kinase Targeted Drugs market is segmented into
Oncology
Cardiovascular
Central Nervous System
Others

Regional and Country-level Analysis
The Receptor Tyrosine Protein Kinase Targeted Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Receptor Tyrosine Protein Kinase Targeted Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Receptor Tyrosine Protein Kinase Targeted Drugs Market Share Analysis
Receptor Tyrosine Protein Kinase Targeted Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Receptor Tyrosine Protein Kinase Targeted Drugs business, the date to enter into the Receptor Tyrosine Protein Kinase Targeted Drugs market, Receptor Tyrosine Protein Kinase Targeted Drugs product introduction, recent developments, etc.

The major vendors covered:
Aslan Pharmaceuticals Pte Ltd
Boehringer Ingelheim GmbH
GamaMabs Pharma SA
Hanmi Pharmaceuticals Co Ltd
Jiangsu Kanion Pharmaceutical Co Ltd
Minerva Neurosciences Inc
Pfizer Inc
Puma Biotechnology Inc
Shanghai Fosun Pharmaceutical (Group) Co Ltd
XuanZhu Pharma Co Ltd
Zensun (Shanghai) Sci & Tech Co Ltd

レポート目次

---

1 Study Coverage
1.1 Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction
1.2 Market Segments
1.3 Key Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Growth Rate by Type
1.4.2 Afatinib Dimaleate
1.4.3 Dacomitinib
1.4.4 Neratinib
1.4.5 Neucardin
1.4.6 Others
1.5 Market by Application
1.5.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Cardiovascular
1.5.4 Central Nervous System
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, Estimates and Forecasts
2.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue 2015-2026
2.1.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales 2015-2026
2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Competitor Landscape by Players
3.1 Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Manufacturers
3.1.1 Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Manufacturers (2015-2020)
3.1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Manufacturers
3.2.1 Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Receptor Tyrosine Protein Kinase Targeted Drugs Revenue in 2019
3.2.5 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Receptor Tyrosine Protein Kinase Targeted Drugs Price by Manufacturers
3.4 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base Distribution, Product Types
3.4.1 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Receptor Tyrosine Protein Kinase Targeted Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size by Type (2015-2020)
4.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2015-2020)
4.1.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type (2015-2020)
4.1.3 Receptor Tyrosine Protein Kinase Targeted Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Receptor Tyrosine Protein Kinase Targeted Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size by Application (2015-2020)
5.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2015-2020)
5.1.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Application (2015-2020)
5.1.3 Receptor Tyrosine Protein Kinase Targeted Drugs Price by Application (2015-2020)
5.2 Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs by Country
6.1.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country
6.1.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Market Facts & Figures by Type
6.3 North America Receptor Tyrosine Protein Kinase Targeted Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs by Country
7.1.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country
7.1.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Facts & Figures by Type
7.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs by Region
8.1.1 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region
8.1.2 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Facts & Figures by Type
8.3 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs by Country
9.1.1 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country
9.1.2 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Receptor Tyrosine Protein Kinase Targeted Drugs Market Facts & Figures by Type
9.3 Central & South America Receptor Tyrosine Protein Kinase Targeted Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs by Country
10.1.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country
10.1.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Aslan Pharmaceuticals Pte Ltd
11.1.1 Aslan Pharmaceuticals Pte Ltd Corporation Information
11.1.2 Aslan Pharmaceuticals Pte Ltd Description and Business Overview
11.1.3 Aslan Pharmaceuticals Pte Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
11.1.5 Aslan Pharmaceuticals Pte Ltd Related Developments
11.2 Boehringer Ingelheim GmbH
11.2.1 Boehringer Ingelheim GmbH Corporation Information
11.2.2 Boehringer Ingelheim GmbH Description and Business Overview
11.2.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
11.2.5 Boehringer Ingelheim GmbH Related Developments
11.3 GamaMabs Pharma SA
11.3.1 GamaMabs Pharma SA Corporation Information
11.3.2 GamaMabs Pharma SA Description and Business Overview
11.3.3 GamaMabs Pharma SA Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
11.3.5 GamaMabs Pharma SA Related Developments
11.4 Hanmi Pharmaceuticals Co Ltd
11.4.1 Hanmi Pharmaceuticals Co Ltd Corporation Information
11.4.2 Hanmi Pharmaceuticals Co Ltd Description and Business Overview
11.4.3 Hanmi Pharmaceuticals Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
11.4.5 Hanmi Pharmaceuticals Co Ltd Related Developments
11.5 Jiangsu Kanion Pharmaceutical Co Ltd
11.5.1 Jiangsu Kanion Pharmaceutical Co Ltd Corporation Information
11.5.2 Jiangsu Kanion Pharmaceutical Co Ltd Description and Business Overview
11.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
11.5.5 Jiangsu Kanion Pharmaceutical Co Ltd Related Developments
11.6 Minerva Neurosciences Inc
11.6.1 Minerva Neurosciences Inc Corporation Information
11.6.2 Minerva Neurosciences Inc Description and Business Overview
11.6.3 Minerva Neurosciences Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
11.6.5 Minerva Neurosciences Inc Related Developments
11.7 Pfizer Inc
11.7.1 Pfizer Inc Corporation Information
11.7.2 Pfizer Inc Description and Business Overview
11.7.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
11.7.5 Pfizer Inc Related Developments
11.8 Puma Biotechnology Inc
11.8.1 Puma Biotechnology Inc Corporation Information
11.8.2 Puma Biotechnology Inc Description and Business Overview
11.8.3 Puma Biotechnology Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
11.8.5 Puma Biotechnology Inc Related Developments
11.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
11.9.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Corporation Information
11.9.2 Shanghai Fosun Pharmaceutical (Group) Co Ltd Description and Business Overview
11.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
11.9.5 Shanghai Fosun Pharmaceutical (Group) Co Ltd Related Developments
11.10 XuanZhu Pharma Co Ltd
11.10.1 XuanZhu Pharma Co Ltd Corporation Information
11.10.2 XuanZhu Pharma Co Ltd Description and Business Overview
11.10.3 XuanZhu Pharma Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.10.4 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
11.10.5 XuanZhu Pharma Co Ltd Related Developments
11.1 Aslan Pharmaceuticals Pte Ltd
11.1.1 Aslan Pharmaceuticals Pte Ltd Corporation Information
11.1.2 Aslan Pharmaceuticals Pte Ltd Description and Business Overview
11.1.3 Aslan Pharmaceuticals Pte Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
11.1.5 Aslan Pharmaceuticals Pte Ltd Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Estimates and Projections by Region
12.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast (2021-2026)
12.2.2 North America: Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Receptor Tyrosine Protein Kinase Targeted Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Receptor Tyrosine Protein Kinase Targeted Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Receptor Tyrosine Protein Kinase Targeted Drugs Market Segments
Table 2. Ranking of Global Top Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Afatinib Dimaleate
Table 5. Major Manufacturers of Dacomitinib
Table 6. Major Manufacturers of Neratinib
Table 7. Major Manufacturers of Neucardin
Table 8. Major Manufacturers of Others
Table 9. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Regions (2015-2020)
Table 13. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Manufacturers (2015-2020)
Table 16. Global Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Receptor Tyrosine Protein Kinase Targeted Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Receptor Tyrosine Protein Kinase Targeted Drugs as of 2019)
Table 18. Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Price (2015-2020) (USD/Pcs)
Table 21. Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Product Type
Table 23. Date of International Manufacturers Enter into Receptor Tyrosine Protein Kinase Targeted Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2015-2020) (K Pcs)
Table 26. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Type (2015-2020)
Table 27. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Type (2015-2020)
Table 29. Receptor Tyrosine Protein Kinase Targeted Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2015-2020) (K Pcs)
Table 31. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Application (2015-2020)
Table 32. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2015-2020) (K Pcs)
Table 33. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country (2015-2020)
Table 34. North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country (2015-2020)
Table 36. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2015-2020) (K Pcs)
Table 37. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2015-2020)
Table 38. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2015-2020) (K Pcs)
Table 39. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2015-2020)
Table 40. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country (2015-2020)
Table 42. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country (2015-2020)
Table 44. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2015-2020)
Table 46. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2015-2020)
Table 56. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country (2015-2020)
Table 60. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2015-2020)
Table 62. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2015-2020)
Table 72. Aslan Pharmaceuticals Pte Ltd Corporation Information
Table 73. Aslan Pharmaceuticals Pte Ltd Description and Major Businesses
Table 74. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Aslan Pharmaceuticals Pte Ltd Product
Table 76. Aslan Pharmaceuticals Pte Ltd Recent Development
Table 77. Boehringer Ingelheim GmbH Corporation Information
Table 78. Boehringer Ingelheim GmbH Description and Major Businesses
Table 79. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Boehringer Ingelheim GmbH Product
Table 81. Boehringer Ingelheim GmbH Recent Development
Table 82. GamaMabs Pharma SA Corporation Information
Table 83. GamaMabs Pharma SA Description and Major Businesses
Table 84. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. GamaMabs Pharma SA Product
Table 86. GamaMabs Pharma SA Recent Development
Table 87. Hanmi Pharmaceuticals Co Ltd Corporation Information
Table 88. Hanmi Pharmaceuticals Co Ltd Description and Major Businesses
Table 89. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Hanmi Pharmaceuticals Co Ltd Product
Table 91. Hanmi Pharmaceuticals Co Ltd Recent Development
Table 92. Jiangsu Kanion Pharmaceutical Co Ltd Corporation Information
Table 93. Jiangsu Kanion Pharmaceutical Co Ltd Description and Major Businesses
Table 94. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Jiangsu Kanion Pharmaceutical Co Ltd Product
Table 96. Jiangsu Kanion Pharmaceutical Co Ltd Recent Development
Table 97. Minerva Neurosciences Inc Corporation Information
Table 98. Minerva Neurosciences Inc Description and Major Businesses
Table 99. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Minerva Neurosciences Inc Product
Table 101. Minerva Neurosciences Inc Recent Development
Table 102. Pfizer Inc Corporation Information
Table 103. Pfizer Inc Description and Major Businesses
Table 104. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Pfizer Inc Product
Table 106. Pfizer Inc Recent Development
Table 107. Puma Biotechnology Inc Corporation Information
Table 108. Puma Biotechnology Inc Description and Major Businesses
Table 109. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Puma Biotechnology Inc Product
Table 111. Puma Biotechnology Inc Recent Development
Table 112. Shanghai Fosun Pharmaceutical (Group) Co Ltd Corporation Information
Table 113. Shanghai Fosun Pharmaceutical (Group) Co Ltd Description and Major Businesses
Table 114. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Shanghai Fosun Pharmaceutical (Group) Co Ltd Product
Table 116. Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Development
Table 117. XuanZhu Pharma Co Ltd Corporation Information
Table 118. XuanZhu Pharma Co Ltd Description and Major Businesses
Table 119. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. XuanZhu Pharma Co Ltd Product
Table 121. XuanZhu Pharma Co Ltd Recent Development
Table 122. Zensun (Shanghai) Sci & Tech Co Ltd Corporation Information
Table 123. Zensun (Shanghai) Sci & Tech Co Ltd Description and Major Businesses
Table 124. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Zensun (Shanghai) Sci & Tech Co Ltd Product
Table 126. Zensun (Shanghai) Sci & Tech Co Ltd Recent Development
Table 127. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 128. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 129. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 130. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 131. North America: Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 132. North America: Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Europe: Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 134. Europe: Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Asia Pacific: Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 136. Asia Pacific: Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 137. Latin America: Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 138. Latin America: Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Middle East and Africa: Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 140. Middle East and Africa: Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Receptor Tyrosine Protein Kinase Targeted Drugs Players
Table 145. Receptor Tyrosine Protein Kinase Targeted Drugs Customers List
Table 146. Receptor Tyrosine Protein Kinase Targeted Drugs Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Receptor Tyrosine Protein Kinase Targeted Drugs Product Picture
Figure 2. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Afatinib Dimaleate Product Picture
Figure 4. Dacomitinib Product Picture
Figure 5. Neratinib Product Picture
Figure 6. Neucardin Product Picture
Figure 7. Others Product Picture
Figure 8. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application in 2020 & 2026
Figure 9. Oncology
Figure 10. Cardiovascular
Figure 11. Central Nervous System
Figure 12. Others
Figure 13. Receptor Tyrosine Protein Kinase Targeted Drugs Report Years Considered
Figure 14. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size 2015-2026 (US$ Million)
Figure 15. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales 2015-2026 (K Pcs)
Figure 16. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Region (2015-2020)
Figure 18. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Region in 2019
Figure 19. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Region (2015-2020)
Figure 20. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Region in 2019
Figure 21. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Receptor Tyrosine Protein Kinase Targeted Drugs Revenue in 2019
Figure 23. Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2015-2020)
Figure 25. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type in 2019
Figure 26. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Type (2015-2020)
Figure 27. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Type in 2019
Figure 28. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Price Range (2015-2020)
Figure 29. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2015-2020)
Figure 30. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application in 2019
Figure 31. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Application (2015-2020)
Figure 32. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Application in 2019
Figure 33. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country in 2019
Figure 36. North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country in 2019
Figure 37. U.S. Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Type in 2019
Figure 42. North America Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Application in 2019
Figure 43. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country in 2019
Figure 46. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country in 2019
Figure 47. Germany Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Type in 2019
Figure 58. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Application in 2019
Figure 59. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Region in 2019
Figure 62. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Region in 2019
Figure 63. China Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Type in 2019
Figure 86. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Application in 2019
Figure 87. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country in 2019
Figure 90. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country in 2019
Figure 91. Mexico Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Type in 2019
Figure 98. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Application in 2019
Figure 99. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country in 2019
Figure 103. Turkey Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Type in 2019
Figure 110. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Application in 2019
Figure 111. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed

---